News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about JP:4523
Recent news which mentions JP:4523
Merck and Eisai say two lung-cancer trials failed to meet their main goals
September 22, 2023
Tickers
ESAIY
SPX
Tags
SPX
ESAIY
JP:4523
From
MarketWatch
Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
June 07, 2023
Tags
JP:4523
From
MarketWatch
New Alzheimer’s drug could bring hope to patients, but could be out of reach for people on Medicare
May 25, 2023
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
Eli Lilly’s positive results from a Alzheimer’s trial seen as ‘potentially very important’
May 03, 2023
Tickers
BIIB
LLY
Tags
LLY
JP:4523
BIIB
From
MarketWatch
Healthcare merger mania scrutinized on Capitol Hill as new deal combines major health systems
April 26, 2023
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
Veterans Health Administration will cover new Alzheimer’s drug. Why won’t Medicare?
March 22, 2023
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
Wall Street predicts approval for another ALS drug
March 21, 2023
Tickers
AMLX
BIIB
IONS
Tags
JP:4523
IONS
BIIB
From
MarketWatch
Medicare just crushed the hopes of 750,000 Alzheimer’s patients a year
March 03, 2023
Tickers
BIIB
SPX
Tags
SPX
JP:4523
RUT
From
MarketWatch
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
Tickers
BIIB
EWTX
RETA
SPX
Tags
XPH
RETA
SPX
From
MarketWatch
New Alzheimer’s drug shows some promise, but has big price tag
February 02, 2023
Tickers
BIIB
ESALF
Tags
ESALF
JP:4523
BIIB
From
MarketWatch
Why the FDA didn’t grant an approval to Lilly’s Alzheimer’s drug
January 20, 2023
Tickers
BIIB
LLY
SPX
Tags
BIIB
JP:4523
LLY
From
MarketWatch
Amid criticism for its handling of another Alzheimer’s drug, FDA will decide this week whether to approve lecanemab
January 03, 2023
Tickers
BIIB
LLY
Tags
BIIB
JP:4523
LLY
From
MarketWatch
New Alzheimer’s drug appears to slow cognitive decline but is ‘not a breakthrough’
December 09, 2022
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
5 things to know about the new Alzheimer’s drug — including why it may be risky for people who take blood thinners
November 30, 2022
Tickers
BIIB
SPX
Tags
JP:4523
BIIB
SPX
From
MarketWatch
Banks are short more than $1 trillion in capital, this analyst says, who fears the shortfall will only get worse
November 30, 2022
Tickers
AMC
AMGN
APE
BABA
Tags
DXY
GME
GC00
From
MarketWatch
A new Alzheimer’s treatment may help some patients, though researchers say more safety data is needed
November 29, 2022
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
Eisai shares fall following report of patient death in Alzheimer’s trial
November 28, 2022
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
What to know about the Alzheimer’s drug data coming out this week
November 28, 2022
Tickers
AXSM
BIIB
LLY
MOR
Tags
BIIB
JP:4523
LLY
From
MarketWatch
One Alzheimer’s drug has failed, but investors are still betting on Biogen and Lilly treatments
November 14, 2022
Tickers
BIIB
ESALF
LLY
MOR
Tags
ESALF
SPX
LLY
From
MarketWatch
Biogen and Eisai make plans to take another Alzheimer’s drug to the FDA
October 25, 2022
Tickers
BIIB
SPX
Tags
SPX
JP:4523
BIIB
From
MarketWatch
Medicare coverage of Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
September 28, 2022
Tickers
BIIB
ESALF
SPX
Tags
ESALF
SPX
JP:4523
From
MarketWatch
Here’s why one strategist says the consumer and related stocks might get a second wind
September 28, 2022
Tickers
AAPL
AMC
AMZN
APE
Tags
QQQ
AAPL
TY00
From
MarketWatch
Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
September 28, 2022
Tickers
BIIB
LLY
Tags
JP:4523
BIIB
LLY
From
MarketWatch
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
September 28, 2022
Tickers
BIIB
ESALY
Tags
BIIB
JP:NIK
JP:4523
From
MarketWatch
Alzheimer’s drug from Eisai, Biogen shows promise in large trial
September 27, 2022
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
Eisai shares sink after Japan regulators seek more data for review of Alzheimer’s drug
December 22, 2021
Tickers
BIIB
Tags
BIIB
JP:4523
From
MarketWatch
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.